Long-term outcomes of 80-watt KTP and 120-watt HPS greenlight photoselective vaporization of the prostate

Urologia Internationalis

Volumn 93, Issue 2, 2014, Pages 229-236

  Broggi, E ^a   May, A ^a   Giretti, G ^a   Tabchouri, N ^a   Lorphelin, H ^a   Brichart, N ^a   Bruyere F ^a,b,c  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b Department of English   (United States)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

Benign prostatic obstruction; GreenLight laser; Prostate laser; Prostate photovaporization

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FOLLOW UP; GREENLIGHT 120 W HPS LASER; GREENLIGHT 80 W POTASSIUM TITANYL PHOSPHATE LASER; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MAXIMUM URINARY FLOW RATE; OUTCOME ASSESSMENT; POLLAKISURIA; POSTOPERATIVE PERIOD; POSTVOID RESIDUAL URINE VOLUME; POTASSIUM TITANYL PHOSPHATE LASER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATE PHOTOSELECTIVE VAPORIZATION; PROSTATE VOLUME; QUALITY OF LIFE; SUPRAPUBIC CATHETER; TRANSURETHRAL RESECTION; TREATMENT FAILURE; URETHROTOMY; URGE INCONTINENCE; URINARY URGENCY; URINE FLOW RATE; UROLOGICAL LASER SYSTEM; ADVERSE EFFECTS; BLADDER CATHETERIZATION; CONVALESCENCE; DEVICES; FRANCE; LOW LEVEL LASER THERAPY; LOWER URINARY TRACT SYMPTOMS; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROSTATIC HYPERPLASIA; SOLID STATE LASER; THERAPEUTIC USE; TIME; TREATMENT OUTCOME; URODYNAMICS;

AGED; FRANCE; HUMANS; LASER THERAPY; LASERS, SOLID-STATE; LOWER URINARY TRACT SYMPTOMS; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME; URINARY CATHETERIZATION; URODYNAMICS;

EID: 84927961728     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000356991     Document Type: Article

References (26)

1. Thangasamy IA, Chalasani V, Bachmann A, Woo HH: Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 2012; 62: 315-323.
2. Lukacs B, Loeffler J, Bruyere F, Blanchet P, Gelet A, Coloby P, De la Taille A, Lemaire P, Baron JC, Cornu JN, Aout M, Rousseau H, Vicaut E; REVAPRO Study Group: Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 2012; 61: 1165-1173.
3. Bachmann A, Muir GH, Collins EJ, Choi BB, Tabatabaei S, Reich OM, Gomez-Sancha F, Woo HH: 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 2012; 61: 600-607.
4. Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T, Shokeir AA: GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 2010; 58: 349-355.
5. Pereira-Correia JA, de Moraes Sousa KD, Santos JB, de Morais Perpetuo D, Lopes-da-Silva LF, Krambeck RL, Muller VJ, Vaz FP: GreenLight HPS TM 120-W laser vaporization vs transurethral resection of the prostate (>60 ml): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 2012; 110: 1184-1189.
6. Descazeaud A, Robert G, Azzousi AR, Ballereau C, Lukacs B, Haillot O, Dumonceau O, Devonec M, Fourmarier M, Saussine C, de la Taille A; Committee for lower urinary tract symptoms of the French Association of Urology: Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int 2009; 103: 1162-1165.
7. Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A: Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007; 51: 1031-1038; discussion 1038-1041.
8. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE: Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005; 19: 1196-1198.
9. Tanchoux C, Pereira H, Brichart N, Bruyere F: Perioperative and early postoperative results of photoselective vaporization of the prostate using fiber 4090 (providing 120 watts) versus fiber MOXY (providing 180 watts). Prog Urol 2012; 22: 529-533.
10. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ: A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 2010; 105: 964-969.
11. Capitan C, Blazquez C, Martin MD, Hernandez V, de la Pena E, Llorente C: GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 2011; 60: 734-739.
12. Ruszat R, Seitz M, Wyler SF, Abe C, Rieken M, Reich O, Gasser TC, Bachmann A: Green-Light laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008; 54: 893-901.
13. Kang SH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, Hwang TK, Kim SW: Long-term follow-up results of photoselective vaporization of the prostate with the 120 W GreenLight HPS laser for treatment of benign prostatic hyperplasia. Korean J Urol 2011; 52: 260-264.
14. Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C: Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 ml: a short-term prospective randomized trial. Urology 2008; 71: 247-251.
15. Bachmann A, Schurch L, Ruszat R, Wyler SF, Seifert HH, Muller A, Lehmann K, Sulser T: Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005; 48: 965-971; discussion 972.
16. Volkan T, Ihsan TA, Yilmaz O, Emin O, Selcuk S, Koray K, Bedi O: Short term outcomes of high power (80 W) potassium-titanylphosphate laser vaporization of the prostate. Eur Urol 2005; 48: 608-613.
17. Malek RS, Kuntzman RS, Barrett DM: Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005; 174: 1344-1348.
18. Bruyere F, Sotto A, Escaravage L, Cariou G, Mignard JP, Coloby P, Hoznek A, Bernard L, Boiteux JP, Thibault M, Soussy CJ, Bugel H; Infectious Disease Committee of the French Association of Urology (AFU): Recommendations of the Infectious Disease Committee of the French Association of Urology (AFU): antibiotic prophylaxis for urological procedures. Prog Urol 2010; 20: 101-108.
19. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A; Standardisation Sub-committee of the International Continence Society: The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-178.
20. Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Muller A, Sulser T: Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 2005; 47: 798-804.
21. Tao W, Xue B, Zang Y, Sun C, Yang D, Zhang Y, Shan Y: The application of 120-W highperformance system GreenLight laser vaporization of the prostate in high-risk patients. Lasers Med Sci 2013; 28: 1151-1157.
22. Rassweiler J, Teber D, Kuntz R, Hofmann R: Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 2006; 50: 969-979; discussion 980.
23. Vinceneux FX, Thebault B, Bruyere F: Urgency rate after prostate photoselective vaporization depends on the definition we use. Prog Urol 2011; 21: 724.
24. Hai MA: Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology 2009; 73: 807-810.
25. Hermanns T, Sulser T, Fatzer M, Baumgartner MK, Rey JM, Sigrist MW, Seifert HH: Laser fibre deterioration and loss of power output during photo-selective 80-w potassiumtitanyl-phosphate laser vaporisation of the prostate. Eur Urol 2009; 55: 679-685.
26. Madersbacher S, Lackner J, Brossner C, Rohlich M, Stancik I, Willinger M, Schatzl G; Prostate Study Group of the Austrian Society of Urology: Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, longterm analysis of 23,123 cases. Eur Urol 2005; 47: 499-504.